Takeda Ventures Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Takeda Ventures Inc
CIK #0001771657
EDGAR Form CIK 2011 - 2026
3 [0001771657]
4 [0001771657]
Form 3/4/5 Subject 2011 - 2026
Calithera Biosciences Inc
Takeda Pharmaceutical Co Ltd
Takeda Ventures Inc
Millennium Pharmaceuticals Inc
Day One Biopharmaceuticals Holding Co LLC
Takeda Pharmaceuticals USA Inc
Xilio Therapeutics Inc
BiomX Inc
Quince Therapeutics Inc
Takeda Pharmaceuticals International AG
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Calithera Biosciences Inc CALA
Series A Convertible Preferred Stock · derivative
2023-04-17 Other 1,000,000
Calithera Biosciences Inc CALA
Series A Convertible Preferred Stock · derivative
2022-07-01 Other 1,000,000 $0.00
Calithera Biosciences Inc CALA
Series A Convertible Preferred Stock · derivative
2022-07-01 Other 1,000,000 $0.00
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
2021-12-08 Sell 110,338 $18.03 1,989,394
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
2021-12-07 Sell 58,190 $19.50 1,134,705
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
2021-12-07 Sell 128,745 $18.43 2,372,770
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
2021-12-06 Sell 97,692 $18.05 1,763,341
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
2021-12-03 Sell 12,517 $18.47 231,189
Day One Biopharmaceuticals Holding Co LLC DAWN
Common Stock
2021-11-24 Other 57,224 $0.00
Xilio Therapeutics Inc XLO
Common Stock
2021-10-26 Conversion 1,475,121
Xilio Therapeutics Inc XLO
Series B Preferred Stock · derivative
2021-10-26 Conversion 1,248,180 $0.00
Xilio Therapeutics Inc XLO
Series C Preferred Stock · derivative
2021-10-26 Conversion 226,941 $0.00
Quince Therapeutics Inc CRTX
Series B Redeemable Convertible Preferred Stock · derivative
2019-05-13 Conversion 319,731 $0.00
Quince Therapeutics Inc CRTX
Series A Redeemable Convertible Preferred Stock · derivative
2019-05-13 Conversion 2,360,071 $0.00
Quince Therapeutics Inc CRTX
Common Stock
2019-05-13 Conversion 2,679,802
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com